Your browser doesn't support javascript.
loading
A novel inhaled phosphodiesterase 4 inhibitor (CHF6001) reduces the allergen challenge response in asthmatic patients.
Singh, D; Leaker, B; Boyce, M; Nandeuil, M A; Collarini, S; Mariotti, F; Santoro, D; Barnes, P J.
Afiliación
  • Singh D; University of Manchester, Medicines Evaluation Unit, University Hospital of South Manchester Foundation Trust, Southmoor Road, Manchester, M23 9QZ, United Kingdom. Electronic address: dsingh@meu.org.uk.
  • Leaker B; Respiratory Clinical Trials Ltd, 18-22 Queen Anne St, London, W1G 8HU, United Kingdom.
  • Boyce M; Hammersmith Medicines Research, Cumberland Avenue, London, NW10 7EW, United Kingdom.
  • Nandeuil MA; Chiesi S.A., 11 Avenue Dubonnet, 92400, Courbevoie, France.
  • Collarini S; Chiesi Farmaceutici S.p.A., Via Palermo 26/A, 43122, Parma, Italy.
  • Mariotti F; Chiesi Farmaceutici S.p.A., Via Palermo 26/A, 43122, Parma, Italy.
  • Santoro D; Chiesi Farmaceutici S.p.A., Via Palermo 26/A, 43122, Parma, Italy.
  • Barnes PJ; National Heart & Lung Institute, Imperial College, London, SW3 6LY, United Kingdom.
Pulm Pharmacol Ther ; 40: 1-6, 2016 10.
Article en En | MEDLINE | ID: mdl-27373438

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Asma / Sulfonamidas / Inhibidores de Fosfodiesterasa 4 / Para-Aminobenzoatos Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male Idioma: En Revista: Pulm Pharmacol Ther Asunto de la revista: FARMACOLOGIA Año: 2016 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Asma / Sulfonamidas / Inhibidores de Fosfodiesterasa 4 / Para-Aminobenzoatos Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male Idioma: En Revista: Pulm Pharmacol Ther Asunto de la revista: FARMACOLOGIA Año: 2016 Tipo del documento: Article